Chester County gene therapy developer raises $112.8M five months after withdrawing IPO plans

The 65-employee company plans to use the proceeds from the stock sale to advance it lead experimental gene therapies and other products in its pipeline.
Click here to view original post

Be the first to comment

Leave a Reply

Your email address will not be published.